Amarantus Bioscience Holdings Inc (AMBS)

[Solantey]

All the talk about "financial engineering" is some what humorous.

A simplified explanation of "financial engineering" as it applies to a penny bio-tech stock such as AMBS is being able to convince someone to buy millions or billions of shares which generates enough cash to keep the company operating until other sources of revenue are created.

I expect the company will eventually become self-substaining in regards to funding operations. The question is when will that happen and how much additional financing with the accompanying dilution will occur before it happens.

I don't think even Gerald knows the answer.